TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	12.66	3.67	14.25
Cash & Short-Term Investments	12.66	3.67	14.25
Cash Growth	245.35%	-74.28%	-
Other Receivables	0.64	0.33	-
Receivables	0.64	0.33	0.1
Other Current Assets	6.31	0.16	0.39
Total Current Assets	19.61	4.16	14.74
Property, Plant & Equipment	0.32	0.2	0.42
Other Long-Term Assets	0.03	-	0.03
Total Assets	19.97	4.36	15.2
Accounts Payable	3.15	1.87	1.92
Accrued Expenses	2.02	1.57	0.84
Current Portion of Leases	0.16	0.02	0.12
Other Current Liabilities	-	0.14	-
Total Current Liabilities	5.33	3.6	2.87
Long-Term Debt	-	2.32	-
Long-Term Leases	0.04	-	0.02
Total Liabilities	5.37	5.92	2.89
Common Stock	0.04	0.01	0
Additional Paid-In Capital	125.4	86.89	71.45
Retained Earnings	-111.12	-88.47	-59.16
Total Common Equity	14.32	-1.58	12.3
Shareholders' Equity	14.59	-1.56	12.3
Total Liabilities & Equity	19.97	4.36	15.2
Total Debt	0.2	2.34	0.14
Net Cash (Debt)	12.45	1.32	14.11
Net Cash Growth	843.49%	-90.65%	-
Net Cash Per Share	0.67	0.11	-
Filing Date Shares Outstanding	43.68	68.01	-
Total Common Shares Outstanding	42.32	68.01	-
Working Capital	14.28	0.56	11.87
Book Value Per Share	0.34	-0.02	-
Tangible Book Value	14.32	-1.58	12.3
Tangible Book Value Per Share	0.34	-0.02	-
Machinery	1.59	1.54	1.5
Leasehold Improvements	0.54	0.54	0.54

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q